Michael F. Salvatore

Decreased plasma membrane expression of striatal dopamine transporter in aging.

Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.

Bilateral effects of unilateral intrastriatal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats.

Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum.

Point source concentration of GDNF may explain failure of phase II clinical trial.

Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia.

Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.

Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation.

GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways.

Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat.

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.

Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19).

Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.

Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.

Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.

Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson's disease progression.